Profil Zat Besi Ibu Hamil di Daerah Endemis Malaria

Pada saat kehamilan, terjadi peningkatan kebutuhan zat besi (Fe) yang diperlukan untuk meningkatkan jumlah sel darah merah ibu dan membentuk sel darah merah janin dan plasenta. Apabila kebutuhan zat besi ini tidak terpenuhi, akan terjadi anemia defisiensi besi. Ibu hamil yang tinggal di daerah endemis malaria rentan terinfeksi malaria, yang berdampak terhadap anemia pada kehamilan. Penelitian ini merupakan penelitian deskriptif dengan desain potong lintang yang bertujuan untuk mengetahui gambaran profil zat besi pada ibu hamil yang berada di daerah endemis malaria vivax kota Bengkulu. Pemeriksaan mikroskopis malaria dan pengambilan sampel darah dilakukan untuk pemeriksaan profil zat besi terhadap 55 orang ibu hamil trimester II dan III yang mempunyai riwayat malaria di 5 wilayah kerja puskesmas. Data yang diperoleh kemudian dilakukan analisis univariat. Pada ibu hamil yang tidak terinfeksi malaria tetapi mempunyai riwayat malaria, 90,5% mengalami anemia, 41,5% mengalami penurunan kadar Total Iron Binding Capacity (TIBC), dan 17% mengalami penurunan kadar Fe serum. Ibu hamil yang terinfeksi malaria vivax selain terjadi penurunan kadar hemoglobin juga disertai dengan penurunan kadar Fe serum dan kadar TIBC. Pada ibu hamil yang menderita malaria falsiparum, terjadi penurunan kadar hemoglobin (Hb) dan kadar TIBC tetapi tidak disertai dengan penurunan kadar Fe serum. Ibu hamil yang terinfeksi malaria maupun yang mempunyai riwayat terinfeksi malaria mengalami anemia pada kehamilan.During pregnancy, the need of iron increase significantly. Iron is needed for increasing the amount of mother’s red blood cell and form the red blood cell of fetus and placenta. If this iron needs is not fulfilled, it could cause iron deficiency anemia. Pregnant women who live in endemic malaria will be vulnerable to be infected malaria, and will cause anemia in pregnancy. This research was aimed to know iron profile in pregnant women that live in endemic malaria area. Malaria microscopic examination and blood sampling for examination of iron profile in 55 pregnant women trimester II and III who have a history of malaria in 5 working area health centers. The data obtained was then performed univariate analysis. The results showed pregnant women who have malaria history, 90.5% are suffering anemia, decreasing of Total Iron Binding Capacity (TIBC) level (41.5%) and 17% Fe serum level (17%). Pregnant women who are infected vivax malaria not only experiencing decrease of hemoglobin level but also experiencing decrease of Fe serum level and TIBC level, while pregnant woman who suffers from falciparum malaria haemoglobin (Hb) level and TIBC are decreasing but not in serum Fe levels. Pregnant women with history of malaria infection will suffer from anemia during pregnancy.

Download Full-text

Association between Serum Ferritin and Iron Parameters with Preeclampsia and its Association with Perinatal Outcome

Ibrahim Cardiac Medical Journal ◽

10.3329/icmj.v7i1-2.53961 ◽

2019 ◽

Vol 7 (1-2) ◽

pp. 64-69

Author(s):

Lipika Ghosh ◽

Rowshan Afrooz ◽

Saleha Begum Chowdhury ◽

Osman Gani ◽

Rokhshana Khatun

Keyword(s):

Pregnant Women ◽

Serum Ferritin ◽

Serum Iron ◽

Binding Capacity ◽

Total Iron ◽

Outcome Variable ◽

Iron Binding ◽

Total Iron Binding Capacity ◽

Iron Parameters ◽

Iron Binding Capacity

Background & objective: To see the relationship between preeclampsia and iron parameters (serum iron, serum ferritin and total iron binding capacity). Methods: The present case-control study was carried out in the Department of Obstetrics & Gynaecology, Dhaka Medical College Hospital (DMCH), Dhaka in collaboration with the Department of Biochemistry, BSMMU, Dhaka over a period of 1 year from July 2012 to June 2013 Pregnant women with preeclampsia admitted in the above-mentioned hospital were considered as case, while the pregnant women without preeclampsia were included as control. A total of 60 women-31 cases and 29 controls were purposively included in the study. The exposure variables were serum ferritin, serum iron and total iron binding capacity (TIBC), while the outcome variable was preeclampsia. The serum iron level > 100 μg/L was considered as hyperferritenemia. Result: Nearly two-thirds of the women were in their 2nd decades of life belonged to lower socioeconomic class. The body mass index was also fairly comparable between the groups with most women having normal BMI. No significant difference was observed between the groups with respect to obstetric variables as well. Level of haemoglobin and hematocrit were also identically distributed between groups. The result showed that a significantly higher proportion (35.5%) preeclamptic women had elevated serum ferritin (> 100 μg/L) as opposed to 10.3% of the control group (p = 0.021). The risk of developing raised serum ferritin in women with preeclampsia was estimated to be 4-fold (95% CI =1.2 – 19.4) higher than that in the normal pregnant women. Analyses also revealed that women with severe preeclampsia had a higher mean serum ferritin (207.3 ± 44.1 ng/ml) than the women with mild preeclampsia (41.7 ± 2.7) and an even higher level compared with the normal pregnant women (21.7 ± 1.4 μg/ml) (p = 0.001). Similar result was observed in serum iron with greater the severity, higher is the level of serum iron (p = 0.067). Conversely, the serum total iron binding capacity (TIBC) was decreased with severity of preeclampsia (p = 0.058). Conclusion: The study concluded that women with preeclamsia might be associated with higher serum ferritin, higher serum iron and lower serum TIBC although it is not known whether the rise in serum ferritin and serum iron precedes or contributes to the clinical manifestations of preeclampsia. Ibrahim Card Med J 2017; 7 (1&2): 64-69

Download Full-text

Assessment of Pro Hepcidin and Related with Iron Profile on Hemodialysis Men Patients

Baghdad Science Journal ◽

10.21123/bsj.13.1.74-81 ◽

2016 ◽

Vol 13 (1) ◽

pp. 74-81

Author(s):

Baghdad Science Journal

Keyword(s):

Renal Failure ◽

Binding Capacity ◽

Transferrin Saturation ◽

Extracellular Fluid ◽

Total Iron ◽

Iron Store ◽

Iron Binding ◽

Total Iron Binding Capacity ◽

Iron Binding Capacity ◽

Iron Profile

Patients with renal failure in the final stages undergo the treatment by hemodialysis. Hemodialysis is used to reinstate the intracellular and extracellular fluid environment, by propagation of molecules in solution through a semipermeable membrane along an electrochemical concentration gradient. Blood catching in the dialysis machine and the recurrent phlebotomy may lead to losing about 1-3 g of iron per year. Prohepcidin hormone is an acute phase protein (type II) that plays a major role in the systemic iron irregularities as it is a mediator of anemia in inflammation and regulator of iron metabolism. This study aims to evaluate the effect of hemodialysis on iron hemostasis and its relationship with prohepcidin as an inflammatory marker. This study includes forty four adult male patients with end-stage renal failure (in pre and post –treated) by means of chronic hemodialysis-HD with mean age (53.27 ± 13.76 years). The following biochemical investigations have been studied: Prohepcidin, Iron, Ferritin, Transferrin, Total Iron-Binding Capacity (TIBC), The Unsaturated Total Iron Binding Capacity (UIBC), and transferrin saturation (TAST).Decrement of Prohepcidin level on hemodialysis patients in post dialysis with non-significantly compared to pre dialysis, while iron and ferritin was increment in post treated than pre- treated with non-significantly.Hemodialysis affects Prohepcidin levels as it was long duration and Glomerular Filtration rate GFR (cock croft equation) and prohepcidin level affect the iron profile related with the iron store depletion.

Download Full-text